BRIEF-Zimmer Biomet announces FDA approval of knee osteoarthritis vaccine
* Zimmer Biomet announces FDA approval of expanded 26-week efficacy claim for gel-one cross-linked hyaluronate for treatment of pain associated with knee osteoarthritis Source text for Eikon:... [Source]
Publication Date:Origin: reuters.com
Category: governmentFilingsNews
Topics: approval, announces, Biomet, Eikon, osteoarthritis Source, associated, for treatment, hyaluronate, cross-linked, gel-one, claim, 26-week efficacy, expanded, Zimmer, vaccine, osteoarthritis, BRIEF-Zimmer
Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/GyqDRqHenEc/idUSASB0AY2F